Proprietary AI analyst is now available
- Public Comps
- Carelabs
Carelabs Valuation Multiples
Discover Carelabs' revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Firefly Neuroscience, Cambridge Cognition, CareView Communications, ContextVision and more.
Carelabs Overview
About Carelabs
Carelabs Co Ltd engages in the provision of healthcare information technology services. The company provides clinic information, clinic customer management software, and digital marketing solutions. Its healthcare media platform includes GoodDak, a mobile medical information service; and Barbietk, a healthcare service that shares domestic cosmetic, skin care, and diet reviews.
Founded
2012
HQ

Employees
120
Website
Financials (FY)
EV
$1M
Valuation Multiples
Start free trialCarelabs Financials
Carelabs reported last fiscal year revenue of $53M and EBITDA of $18M.
In the same fiscal year, Carelabs generated $52M in gross profit, $18M in EBITDA, and $13M in net income.
Carelabs P&L
In the most recent fiscal year, Carelabs reported revenue of $53M and EBITDA of $18M.
Carelabs is profitable as of last fiscal year, with gross margin of 98%, EBITDA margin of 34%, and net margin of 23%.
Financial data powered by Morningstar, Inc.
Carelabs Stock Performance
Carelabs has current market cap of $24M, and enterprise value of $1M.
Market Cap Evolution
Carelabs' stock price is $1.26.
Carelabs share price decreased by 8.5% in the last 30 days, and by 45.4% in the last year.
Carelabs has an EPS (earnings per share) of $0.64.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1M | $24M | -3.1% | -8.5% | -18.9% | -45.4% | $0.64 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCarelabs Valuation Multiples
Carelabs trades at 0.0x EV/Revenue multiple, and 0.1x EV/EBITDA.
Carelabs Financial Valuation Multiples
As of June 6, 2026, Carelabs has market cap of $24M and EV of $1M.
Carelabs has a P/E ratio of 2.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Carelabs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Carelabs Margins & Growth Rates
In the most recent fiscal year, Carelabs reported gross margin of 98%, EBITDA margin of 34%, and net margin of 23%.
Carelabs Margins
Carelabs Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Carelabs Operational KPIs
Carelabs' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.5M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Carelabs Competitors
Carelabs competitors include Firefly Neuroscience, Cambridge Cognition, CareView Communications, ContextVision, EBM Technologies, Beamtree, Diagnos, MRSO, CurveBeam AI and NextPlat.
Most Carelabs public comparables operate across Healthcare Software, Health Data & Analytics, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 20.7x | - | (1.2x) | - | |||
| 1.8x | 1.6x | (33.8x) | (110.1x) | |||
| - | - | - | - | |||
| 1.8x | 1.8x | 9.5x | 9.5x | |||
| 2.2x | - | 19.4x | - | |||
| 0.9x | 1.2x | (84.7x) | (84.7x) | |||
| 230.9x | - | (6.8x) | - | |||
| 1.0x | 1.0x | (38.4x) | - | |||
This data is available for Pro users. Sign up to see all Carelabs competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Carelabs
Carelabs has acquired 2 companies to date.
Last acquisition by Carelabs was on July 16th 2019. Carelabs acquired Eunogo for undisclosed valuation.
Latest Acquisitions by Carelabs
| Description | - | BNKLAB is a Seoul-based mobile app developer and publisher specializing in social discovery platforms for dating and networking. The company operates the 'BNK' app, which uses location-based matching and video profiles to connect over 500,000 users in South Korea. Launched in 2019, BNKLAB integrates gamified features and safety verification to facilitate real-world meetups among young professionals. |
| HQ Country | ||
| HQ City | Singapore | Seoul |
| Deal Date | 16 Jul 2019 | 10 Jul 2018 |
| Valuation | undisclosed | $10M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Carelabs acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by Carelabs
Carelabs has invested in 5 companies to date.
Latest investment by Carelabs was on May 12th 2023. Carelabs invested in Humanscape in their $15M Series C round (EV/Revenue multiple available to Pro users).
Latest Investments by Carelabs
| Description | Humanscape is a Seoul-headquartered health-tech firm focused on rare disease data platforms since 2018. The company aggregates genotype, clinical, and phenotype data from 100,000 patients across 500 diseases, enabling pharma partners like Novartis to accelerate drug trials by 30 percent. Its blockchain-secured database supports AI model training for precision medicine. Humanscape operates in South Korea, the United States, and Japan, with integrations to EHRs from Allscripts and Cerner. The platform has facilitated 20 investigational new drug applications. | - | Brain Gear is a medical device manufacturer producing light-therapy systems for neurological conditions. Based in Europe, the company offers wearable devices emitting specific wavelengths for migraine relief and cognitive enhancement. Dagear.net details FDA-cleared photobiomodulation units. Brain Gear targets treatments for traumatic brain injury and depression. Its systems use near-infrared light delivered through helmets and panels. | Brain Gear is a medical device manufacturer producing light-therapy systems for neurological conditions. Based in Europe, the company offers wearable devices emitting specific wavelengths for migraine relief and cognitive enhancement. Dagear.net details FDA-cleared photobiomodulation units. Brain Gear targets treatments for traumatic brain injury and depression. Its systems use near-infrared light delivered through helmets and panels. | |
| HQ Country | |||||
| HQ City | Seoul | - | Daejeon | Daejeon | |
| Deal Date | 12 May 2023 | 9 May 2022 | 18 Jan 2022 | 4 Aug 2021 | |
| Round | Series C | Series A | Series A | Series A | |
| Raised | $15M | $17M | $2M | $2M | |
| Investors | Carelabs; GC Biopharma; Hana Securities; Kyobo Securities; Mint Venture Partners; Shinhan Asset Management; Shinhan Bank; UTC Investment | Bokwang Investment; Carelabs; Dt& Investment; E&Venture Partners; Industrial Bank of Korea; KB Investment; Magellan Technology Investment; Samsung Venture Investment; TINVESTMENT | Bigbang Angels; Carelabs; Center for Creative Economy and Innovation; CNTTECH | Bigbang Angels; Carelabs | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Carelabs investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Carelabs
| When was Carelabs founded? | Carelabs was founded in 2012. |
| Where is Carelabs headquartered? | Carelabs is headquartered in South Korea. |
| How many employees does Carelabs have? | As of today, Carelabs has over 120 employees. |
| Is Carelabs publicly listed? | Yes, Carelabs is a public company listed on Korea Exchange. |
| What is the stock symbol of Carelabs? | Carelabs trades under 263700 ticker. |
| When did Carelabs go public? | Carelabs went public in 2018. |
| Who are competitors of Carelabs? | Carelabs main competitors include Firefly Neuroscience, Cambridge Cognition, CareView Communications, ContextVision, EBM Technologies, Beamtree, Diagnos, MRSO, CurveBeam AI, NextPlat. |
| What is the current market cap of Carelabs? | Carelabs' current market cap is $24M. |
| What is the current revenue of Carelabs? | Carelabs' last fiscal year revenue is $53M. |
| What is the current EV/Revenue multiple of Carelabs? | Current revenue multiple of Carelabs is 0.0x. |
| Is Carelabs profitable? | No, Carelabs is not profitable. |
| How many companies Carelabs has acquired to date? | As of June 2026, Carelabs has acquired 2 companies. |
| What was the largest acquisition by Carelabs? | $10M acquisition of BNKLAB on 10th July 2018 was the largest M&A Carelabs has done to date. |
| What companies Carelabs acquired? | Carelabs acquired BNKLAB and Eunogo. |
| In how many companies Carelabs has invested to date? | As of June 2026, Carelabs has invested in 5 companies. |
| What was the last Carelabs investment? | On 12th May 2023 Carelabs invested in Humanscape, participating in a $15M Series C round, alongside GC Biopharma, Hana Securities, Kyobo Securities, Mint Venture Partners, Shinhan Asset Management, Shinhan Bank, and UTC Investment. |
| In what companies Carelabs invested in? | Carelabs invested in Goodoc, Humanscape, Medi Staff, Sphere, and Brain Gear. |
See public comps similar to Carelabs
Lists including Carelabs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

